Gonorrhea is a sexually transmitted disease (STD). It is caused by bacterium Neisseria gonorrhoeae. It tends to infect warm, moist areas of the body like urethra, eyes, throat, vagina, anus, and female reproductive tract. Gonorrhea transfers from person to person through unprotected sex. Newborns can be infected during delivery if their mothers are infected. In infants, disease most commonly affects the eyes. Symptoms usually happen within two to 14 days after exposure. However, some people affected by gonorrhea never develop prominent symptoms. People are more likely to spread the infection to other partners when they don't have notable symptoms
Gonorrhea therapeutics market is anticipated to grow in the forecast period owing to driving factors such as the Increasing prevalence of gonorrhea, coupled with the rising public awareness about STDs (Sexually-Transmitted Diseases). Moreover, advances in relevant diagnostic methods, rising investments by prominent players for the growing demand are also offering opportunities in the market growth during the forecast period.
The "Global Gonorrhea therapeutics Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Gonorrhea therapeutics market with detailed market segmentation by infection type, treatment, by route of administration, by distribution channel and geography. The global gonorrhea therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gonorrhea therapeutics market players and offers key trends and opportunities in the market.
The global gonorrhea therapeutics market is segmented on the basis of infection type, treatment, by route of administration, by distribution channel. Based on infection type, the market is segmented as Uncomplicated Gonococcal Infection, Gonococcal Arthritis and Gonococcal Meningitis and Endocarditis. Based on treatment, the market is segmented as monotherapy and dual therapy. Based on route of administration, the market is segmented as Oral and Injectable. Based on distribution channel the market is segmented as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others
Get more information on this report :
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Gonorrhea therapeutics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Gonorrhea therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting gonorrhea therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gonorrhea therapeutics market in these regions.
Get more information on this report :
The report covers key developments in the gonorrhea therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gonorrhea therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for gonorrhea therapeutics in the global market. Below mentioned is the list of few companies engaged in the gonorrhea therapeutics market.
The report also includes the profiles of key gonorrhea therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
Becton Dickinson and Company
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.